HPV testing 1
Monday, October 9, 2017
•
FC 05
•
8:00 AM
>
9:30 AM
•
HPV testing 1
•
G 104
•
FC 05-01
•
Implementation validation of the PapilloCheck ® kit for genotyping human papillomaviruses (HPV) in PreservCyt liquid medium
See abstract
>
B.
B.
VANMASSENHOVE
•
FC 05-02
•
A comparison of the performance of PapType using Cytoflex and Attune flow cytometer platforms on cervical screening samples collected from PreservCyt
See abstract
>
J.
Jack
CUZICK
•
FC 05-03
•
The transition from HC2® test to Cobas® 4800 test in the HPV primary screening of the Florentine area
See abstract
>
F.
Francesca
CAROZZI
•
FC 05-04
•
Comparison of validated molecular methods for HPV primary screening test: HC2 ® test vs. Cobas® 4800 test
See abstract
>
F.
Francesca
CAROZZI
•
FC 05-05
•
Comparison of three different systems to test for the presence of a hr-HPV infection in symptomatic and follow-up patients.
See abstract
>
A.
A.J.C.
VAN DEN BRULE
•
FC 05-06
•
The concordance of HPV DNA and HPV oncogenes mRNA in adenocarcinoma and squamous carcinoma of cervix
See abstract
>
Y.
Y.
SONG
•
FC 05-07
•
An update on the international HPV reference center
See abstract
>
C.
C.
EKLUND
•
FC 05-08
•
Detection of HPV mRNA and HPV DNA up to 8 years before diagnosis of CIN3+
See abstract
>
O.
O.
FORSLUND
•
FC 05-09
•
HPV DNA genotype agreement and clinical performance in first-void urine and cervical samples in a referral population in Belgium
See abstract
>
S.
S.
VAN KEER
|